James R. Tata

3.2k total citations
62 papers, 1.7k citations indexed

About

James R. Tata is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Infectious Diseases. According to data from OpenAlex, James R. Tata has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Infectious Diseases. Recurrent topics in James R. Tata's work include HIV/AIDS drug development and treatment (15 papers), Receptor Mechanisms and Signaling (13 papers) and HIV Research and Treatment (12 papers). James R. Tata is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), Receptor Mechanisms and Signaling (13 papers) and HIV Research and Treatment (12 papers). James R. Tata collaborates with scholars based in United States. James R. Tata's co-authors include Arthur A. Patchett, Ravi P. Nargund, Wanda Chan, Gerard J. Hickey, Bridget Butler, David B. Johnston, Khaled J. Barakat, Kwan Hon Cheng, Steven L. Colletti and James M. Balkovec and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Diabetes.

In The Last Decade

James R. Tata

61 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James R. Tata United States 21 637 606 412 249 184 62 1.7k
Dennis Dean United States 25 614 1.0× 571 0.9× 183 0.4× 120 0.5× 146 0.8× 66 2.0k
Gino Salituro United States 20 803 1.3× 392 0.6× 282 0.7× 111 0.4× 194 1.1× 46 1.6k
James V. Heck United States 19 614 1.0× 483 0.8× 157 0.4× 432 1.7× 113 0.6× 30 1.6k
John W. Clader United States 28 953 1.5× 1.4k 2.3× 85 0.2× 154 0.6× 325 1.8× 72 3.1k
Ann E. Weber United States 32 1.4k 2.1× 1.4k 2.4× 797 1.9× 51 0.2× 146 0.8× 78 3.2k
Daniela Barlocco Italy 28 1.4k 2.1× 986 1.6× 148 0.4× 25 0.1× 121 0.7× 145 2.6k
Gerhart Kurz Germany 27 806 1.3× 231 0.4× 99 0.2× 30 0.1× 309 1.7× 67 2.0k
Hiskias G. Keizer Netherlands 16 631 1.0× 294 0.5× 54 0.1× 27 0.1× 98 0.5× 27 1.9k
Tomoyuki Ohe Japan 23 429 0.7× 348 0.6× 50 0.1× 80 0.3× 53 0.3× 61 1.3k
Fatima Z. Basha Pakistan 19 348 0.5× 554 0.9× 130 0.3× 52 0.2× 36 0.2× 67 1.4k

Countries citing papers authored by James R. Tata

Since Specialization
Citations

This map shows the geographic impact of James R. Tata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Tata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Tata more than expected).

Fields of papers citing papers by James R. Tata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Tata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Tata. The network helps show where James R. Tata may publish in the future.

Co-authorship network of co-authors of James R. Tata

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Tata. A scholar is included among the top collaborators of James R. Tata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Tata. James R. Tata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruprecht, Benjamin, Julie Di Bernardo, Zhao Wang, et al.. (2020). A mass spectrometry-based proteome map of drug action in lung cancer cell lines. Nature Chemical Biology. 16(10). 1111–1119. 34 indexed citations
2.
Lin, Songnian, Fengqi Zhang, Guoqiang Jiang, et al.. (2015). A novel series of indazole-/indole-based glucagon receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 25(19). 4143–4147. 14 indexed citations
3.
Schmidt, Darby, Subharekha Raghavan, Hong C. Shen, et al.. (2010). Anthranilic acid replacements in a niacin receptor agonist. Bioorganic & Medicinal Chemistry Letters. 20(11). 3426–3430. 17 indexed citations
4.
Ding, Fa‐Xiang, Hong C. Shen, Mihajlo L. Krsmanovic, et al.. (2010). Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A. Bioorganic & Medicinal Chemistry Letters. 20(11). 3372–3375. 10 indexed citations
5.
Shen, Hong C., Fa‐Xiang Ding, Qiaolin Deng, et al.. (2009). Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(18). 5314–5320. 22 indexed citations
6.
Schmidt, Darby, Subharekha Raghavan, Ester Carballo‐Jane, et al.. (2009). Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia. Bioorganic & Medicinal Chemistry Letters. 19(16). 4768–4772. 10 indexed citations
7.
Imbriglio, Jason E., Rui Liang, Subharekha Raghavan, et al.. (2009). GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole–tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a. Bioorganic & Medicinal Chemistry Letters. 19(8). 2121–2124. 13 indexed citations
8.
Shen, Hong C., Fa‐Xiang Ding, Qiaolin Deng, et al.. (2009). A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(19). 5716–5721. 29 indexed citations
9.
Deng, Qiaolin, Richard T. Beresis, Ning Ren, et al.. (2008). Molecular modeling aided design of nicotinic acid receptor GPR109A agonists. Bioorganic & Medicinal Chemistry Letters. 18(18). 4963–4967. 20 indexed citations
10.
Lai, Eseng, M. Gerard Waters, James R. Tata, et al.. (2008). Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans. Journal of clinical lipidology. 2(5). 375–383. 41 indexed citations
11.
Shen, Hong C., Michael J. Szymonifka, Qiaolin Deng, et al.. (2007). Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A. Bioorganic & Medicinal Chemistry Letters. 17(24). 6723–6728. 16 indexed citations
12.
Raghavan, Subharekha, Zhijian Lu, Kevin T. Chapman, et al.. (2007). Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virus. Bioorganic & Medicinal Chemistry Letters. 17(19). 5432–5436. 8 indexed citations
13.
Lu, Zhijian, Carrie A. Rutkowski, David B. Olsen, et al.. (2005). Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus. Bioorganic & Medicinal Chemistry Letters. 15(23). 5311–5314. 8 indexed citations
14.
Kim, Ronald M., Kevin T. Chapman, William A. Schleif, et al.. (2004). P1′ oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1. Bioorganic & Medicinal Chemistry Letters. 14(18). 4651–4654. 21 indexed citations
15.
Qureshi, Sajjad A., Mari R. Candelore, Dan Xie, et al.. (2004). A Novel Glucagon Receptor Antagonist Inhibits Glucagon-Mediated Biological Effects. Diabetes. 53(12). 3267–3273. 87 indexed citations
16.
Lu, Zhijian, Subharekha Raghavan, Mark G. Charest, et al.. (2003). Design and synthesis of highly potent HIV protease inhibitors with activity against resistant virus. Bioorganic & Medicinal Chemistry Letters. 13(10). 1821–1824. 12 indexed citations
17.
Cheng, Yuan, Fengqi Zhang, Thomas A. Rano, et al.. (2002). Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-Resistant viral strains. Bioorganic & Medicinal Chemistry Letters. 12(17). 2419–2422. 23 indexed citations
18.
Chiba, Masato, Lixia Jin, William Neway, et al.. (2001). P450 interaction with HIV protease inhibitors: relationship between metabolic stability, inhibitory potency, and P450 binding spectra.. PubMed. 29(1). 1–3. 57 indexed citations
19.
Rano, Thomas A., Yuan Cheng, Fengqi Zhang, et al.. (2000). Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor library. Bioorganic & Medicinal Chemistry Letters. 10(14). 1527–1530. 15 indexed citations
20.
Patchett, Arthur A., Ravi P. Nargund, James R. Tata, et al.. (1995). Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.. Proceedings of the National Academy of Sciences. 92(15). 7001–7005. 268 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis Dean Breakdown of academic impact, for papers by Gino Salituro Breakdown of academic impact, for papers by James V. Heck Breakdown of academic impact, for papers by John W. Clader Breakdown of academic impact, for papers by Ann E. Weber Breakdown of academic impact, for papers by Daniela Barlocco Breakdown of academic impact, for papers by Gerhart Kurz Breakdown of academic impact, for papers by Hiskias G. Keizer Breakdown of academic impact, for papers by Tomoyuki Ohe Breakdown of academic impact, for papers by Fatima Z. Basha
Rankless by CCL
2026